This pharma stock gives 650 percent return in 6 months

17 Sep , 2021 By : Kanchan Joshi

Multibagger stock: On account of NSE Nifty, BSE Sensex, mid-cap and small-cap indices soaring to record highs, a handful of shares have entered into the elite list of multibagger stocks in 2021. ANG Lifesciences shares are one of them. This pharma stock has surged from Rs85.50 per stock levels to Rs642.10 apiece (today at 12:44 PM at BSE) in last six month — logging around 650 per cent return for its shareholders in this period.

ANG Lifesciences share price history

This multibagger stock has been under profit-booking pressure as it has gone down around 5 per cent in the intraday trade session. In the last 5 trade sessions, it has made its highest closing at Rs744.70 apiece but couldn't sustain at highs and went down from these levels to Rs642.10 per equity share today. However, in last one month, this pharma stock has surged from Rs527 per shares to Rs642.10 per stock levels — logging around 22 per cent rise. Similarly, in the last six month, this multibagger stock jumped from Rs85.50 per stock levels to Rs642.10 apiece — delivering near 650 per cent return to its shareholders.

Impact on investors' money

Taking cue from this multibagger stock's price history, if an investor had invested Rs1 lakh in this counter one month ago, its Rs1 lakh would have become Rs1.22 lakh in this period, if the investor had remained invested in this stock throughout this period. Similarly, if an investor had invested Rs1 lakh in this counter 3 months ago, its Rs1 lakh would have turned to Rs3.56 lakh as the multibagger stock has surged from Rs180.35 per equity share (close price on 16th June 2021) to Rs642.10 apiece today — near 3.56 times.

However, if an investor had invested Rs1 lakh in this counter six month ago, its Rs1 lakh would have become Rs7.50 lakh today, if the investor had remained invested in the counter till date.

ANG Lifesciences share price outlook

Suggesting investors to buy this multibagger stock for more gains; Sumeet Bagadia, Executive Director at Choice Broking said, “One can buy this counter at current market price for Rs750 to rs 800 targets maintaining stop loss at Rs600 apiece." He said that the pharma stock has strong support at Rs600 to Rs625.